Mesalamine

Drug Usage Statistics, United States, 2004 - 2014

Number of Prescriptions Over Time (2004 - 2014)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2004 193 -
2005 205  12
2006 232  27
2007 270  38
2008 195  75
2009 158  37
Year Rank Change
2010 154  4
2011 150  4
2012 186  36
2013 224  38
2014 183  41

Patient Out-Of-Pocket Cost Over Time (2004 - 2014)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2014)
Mesalamine (this drug) 3,530,952
Sulfasalazine 2,239,532

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Apriso
  • Asacol
  • Asacol HD
  • Canasa
  • Delzicol
  • Lialda
  • Pentasa
  • Rowasa
  • Sfrowasa
Generic Drug Synonyms and Salts
  • Mesalamine

FDA Approval Information

Established Pharmacologic Class (EPC): Aminosalicylate
Initial FDA approval date: 12/24/1987
First FDA applicant: Meda Pharmaceuticals Inc
First dosage form: Enema (rectal)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2004-2014. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 17.0. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

Which of these drugs causes acute kidney injury? The Top 250 Drugs by ClinCalc Academy
©2017 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Mar 4, 2017
Back to Top
Top